BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29

• Press Releases

  Rapport Therapeutics Reports Third Quarter Financials and Provides Business Update

  November 7, 2024

   · 

  17 min read
• Press Releases

  ImPact Biotech Presents Updated Interim Phase 3 Data from ENLIGHTED Study of Padeliporfin VTP in Low Grade UTUC at EMUC 2024

  November 7, 2024

   · 

  5 min read
• Press Releases

  MoonLake Immunotherapeutics Reports Third Quarter 2024 Financial Results and Provides a Business Update

  November 7, 2024

   · 

  18 min read
• Press Releases

  ADC Therapeutics Reports Third Quarter and Year-to-Date 2024 Financial Results and Provides Operational Update

  November 7, 2024

   · 

  21 min read
• Press Releases

  Candel Therapeutics to Present at Jefferies London Healthcare Conference 2024

  November 7, 2024

   · 

  4 min read
• Press Releases

  Aprea Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

  November 7, 2024

   · 

  12 min read
• Press Releases

  PepGen Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

  November 7, 2024

   · 

  10 min read
• Press Releases

  Aclipse Therapeutics Selected to Present M102 ALS Clinical Development Program at Prestigious ALS and Motor Neurone Disease Symposia

  November 7, 2024

   · 

  3 min read
• Press Releases

  Edgewise Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

  November 7, 2024

   · 

  13 min read
• Press Releases

  Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant Glioma

  November 7, 2024

   · 

  7 min read